Artisan Pharma

About:

Artisan Pharma provides critical-care and hospital-based therapeutics to patients, treating physicians, and payors.

Website: http://www.artisanpharma.net

Top Investors: EDBI, Asahi Kasei, New Leaf Venture Partners, Novaquest Capital Management, NGN Capital

Description:

Artisan Pharma, Inc., a biopharmaceutical company, provides critical-care and hospital-based therapeutics to patients, treating physicians, and payors in the United States and internationally. It offers ART-123, a novel, recombinant, and soluble thrombomodulin for the treatment of disseminated intravascular coagulation in sepsis. The company offers its products in Japan, China, Taiwan, and Korea. It has a strategic manufacturing alliance with A-Bio Pharma Pte Ltd. Artisan Pharma, Inc. was formerly known as Artisan Therapeutics, Inc. and changed its name to Artisan Pharma, Inc. in September 2006. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.

Total Funding Amount:

$85.4M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2006-01-01

Contact Email:

info(AT)artisanpharma.net

Founders:

Jeffrey D. Wager

Number of Employees:

11-50

Last Funding Date:

2010-07-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai